CHU Toulouse, Hôpital Rangueil

Toulouse 50032 31059

1 studies enrolling now · 6 studies all time

What they study most

Bradycardia, Coronary Artery Disease, ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma, Heart Failure With Left Bundle Branch Block, Heart Failure With Preserved Ejection Fraction (HFpEF)

Studies at this site

• ELEVATE-HFpEF Clinical Study — Recruiting now
• Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence — Recruiting now
• Micra AV Transcatheter Pacing System Post-Approval Registry — Completed
• AdaptResponse Clinical Trial — Completed
• RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort) — Completed
• RESOLUTE ONYX Post-Approval Study — Completed